MyAverix Finance
HK · Healthcare
Hbm Holdings Ltd (2142)
Biotechnology
Hbm Holdings Ltd (2142) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $9.93B, P/E ratio is 12.65, net margin is 57.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2142
Hbm Holdings Ltd (2142) — FAQ
What is Hbm Holdings Ltd's market cap?
Hbm Holdings Ltd (2142) has a reported market cap of $9.93B (data as of 2026-05-21).
What is 2142's P/E ratio?
The price-to-earnings (P/E) ratio for Hbm Holdings Ltd (2142) is 12.65 (data as of 2026-05-21).
Does Hbm Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hbm Holdings Ltd (2142). Check the MyAverix Finance app for the latest dividend data.
What sector is Hbm Holdings Ltd in?
Hbm Holdings Ltd (2142) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2142 listed on?
2142 is listed on HK.
What is Hbm Holdings Ltd's net margin?
Hbm Holdings Ltd (2142) reports a net margin of 57.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.